Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a matched gift and support Jewish journalism. DONATE NOW
Culture

Tay-Sachs Association Turns 50

When it was founded in 1957, the National Tay-Sachs & Allied Diseases Association was no more than a group of New York parents who had dedicated themselves to ending Tay-Sachs and the genetic diseases related to it. Tay-Sachs may still be around, but at the NTSAD’s 50th anniversary gala in October, the group will have much to celebrate.

Since its humble beginnings, the organization has made enormous strides in both helping to prevent the disease and aiding families grappling with it. In its half-century of existence, the association has been involved in everything from research and testing to establishing an extensive support network for parents.

In the ’70s, the NTSAD helped fund the first mass-screenings for Tay-Sachs, a practice that it continues to this day. The group has helped fund biannual research symposia and has been active in giving seed grants to researchers, who then can take their results to such wealthier sponsors as the National Institutes of Health.

The NTSAD also has been an active educator, publishing newsletters, visiting schools and performing genetic counseling.

If there is an arena in which the group has evolved, it is fundraising. The group, which once relied on lavish gala dinners to raise money, now looks more to smaller community-run efforts, like walkathons and home-run derbies.

But with its golden anniversary this fall, the NTSAD will be “recapturing some of that old magic,” said Kim Crawford, the association’s director of member services. The dinner, said Marion Yanovsky, co-president of the association’s New York chapter, has been designed “to celebrate progress that’s been made — and to look to the future.”

And what does that future hold?

Ultimately, Yanovsky said, the hope is to eliminate Tay-Sachs and “put ourselves out of a job.”

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news. All donations are still being matched by the Forward Board - up to $100,000 until April 24.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.